• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶血性尿毒症综合征:预后因素

Haemolytic uraemic syndrome: prognostic factors.

作者信息

Green D A, Murphy W G, Uttley W S

机构信息

Royal Hospital for Sick Children, Royal Infirmary, Edinburgh, UK.

出版信息

Clin Lab Haematol. 2000 Feb;22(1):11-4. doi: 10.1046/j.1365-2257.2000.00272.x.

DOI:10.1046/j.1365-2257.2000.00272.x
PMID:10762298
Abstract

Haemolytic uraemic syndrome (HUS) associated with Escherichia coli O157:H7 is the commonest cause of acute renal failure (ARF) in childhood. Production of verotoxin by the organism is pivotal in the pathogenesis of the disease. Verotoxin binds to a receptor on blood and endothelial cells, expressed as the P1 blood group antigen on red blood cells. A protective effect of the P1 phenotype has been proposed in this disease. This study investigates prognostic factors and the relationship between outcome and P1 phenotype in 27 cases of diarrhoea-associated HUS. A poor outcome as defined by the presence of chronic renal failure (CRF), hypertension or proteinuria on 6 month follow-up was associated with the age of the patient at presentation and with the following clinical markers: maximum WBC and duration of raised WBC, duration of anuria and duration of need for dialysis. None of these outcome measures or prognostic factors, and no extra-renal manifestations of the disease were associated with P1 phenotype.

摘要

与大肠杆菌O157:H7相关的溶血性尿毒综合征(HUS)是儿童急性肾衰竭(ARF)最常见的病因。该病原体产生的志贺毒素在疾病的发病机制中起关键作用。志贺毒素与血液和内皮细胞上的一种受体结合,这种受体在红细胞上表现为P1血型抗原。有人提出P1表型在这种疾病中具有保护作用。本研究调查了27例腹泻相关性HUS患者的预后因素以及预后与P1表型之间的关系。随访6个月时,根据是否存在慢性肾衰竭(CRF)、高血压或蛋白尿所定义的不良预后与患者就诊时的年龄以及以下临床指标有关:白细胞计数最高值和白细胞升高持续时间、无尿持续时间以及需要透析的持续时间。这些预后指标或预后因素以及该疾病的肾外表现均与P1表型无关。

相似文献

1
Haemolytic uraemic syndrome: prognostic factors.溶血性尿毒症综合征:预后因素
Clin Lab Haematol. 2000 Feb;22(1):11-4. doi: 10.1046/j.1365-2257.2000.00272.x.
2
Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.大肠杆菌O157:H7感染期间的相对肾脏保护作用:与静脉补液扩容的关系
Pediatrics. 2005 Jun;115(6):e673-80. doi: 10.1542/peds.2004-2236.
3
[Haemolytic uraemic syndrome in children--a systematic review].
Ugeskr Laeger. 2012 May 7;174(19):1302-7.
4
Desperately seeking diarrhoea: outbreak of haemolytic uraemic syndrome caused by emerging sorbitol-fermenting shiga toxin-producing Escherichia coli O157:H-, Germany, 2009.拼命寻找腹泻:2009 年德国由新兴山梨醇发酵产志贺毒素大肠杆菌 O157:H-引起的溶血性尿毒综合征爆发。
Zoonoses Public Health. 2011 Dec;58(8):567-72. doi: 10.1111/j.1863-2378.2011.01405.x. Epub 2011 Apr 6.
5
Hemolytic uremic syndrome risk and Escherichia coli O157:H7.溶血尿毒综合征风险与大肠杆菌O157:H7
Emerg Infect Dis. 2005 Dec;11(12):1955-7. doi: 10.3201/eid1112.050607.
6
[Post-diarrheal haemolytic uremic syndrome: when shall we consider it? Which follow-up?].[腹泻后溶血性尿毒症综合征:何时应予以考虑?如何进行随访?]
Arch Pediatr. 2011 Jul;18(7):823-30. doi: 10.1016/j.arcped.2011.04.001. Epub 2011 May 14.
7
Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.挪威儿童溶血尿毒综合征的临床特征、治疗干预及长期情况:一项1999年至2008年的全国性回顾性研究
BMC Infect Dis. 2016 Jun 13;16:285. doi: 10.1186/s12879-016-1627-7.
8
Does blood type B protect against haemolytic uraemic syndrome? An analysis of the 1996 Sakai outbreak of Escherichia coli O157:H7 (VTEC O157) infection. The Osaka HUS Critical Care Study Group.B 型血能预防溶血性尿毒综合征吗?对 1996 年阪井大肠杆菌 O157:H7(产志贺毒素大肠杆菌 O157)感染疫情的分析。大阪溶血性尿毒综合征重症监护研究小组。
J Infect. 2000 Jul;41(1):45-9. doi: 10.1053/jinf.2000.0677.
9
Risk of haemolytic uraemic syndrome caused by shiga-toxin-producing Escherichia coli infection in adult women in Japan.日本成年女性中由产志贺毒素大肠杆菌感染引起的溶血尿毒综合征风险。
Epidemiol Infect. 2016 Apr;144(5):952-61. doi: 10.1017/S0950268815002289. Epub 2015 Oct 16.
10
A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman, Argentina.阿根廷图库曼地区溶血尿毒综合征患儿的临床与细菌学研究。
Jpn J Infect Dis. 1999 Apr;52(2):33-7.

引用本文的文献

1
Blood Groups in Infection and Host Susceptibility.感染与宿主易感性中的血型
Clin Microbiol Rev. 2015 Jul;28(3):801-70. doi: 10.1128/CMR.00109-14.
2
Trochanteric area pain, the result of a quartet of bursal inflammation.转子区疼痛,是一组滑囊炎的结果。
World J Orthop. 2013 Jul 18;4(3):100-2. doi: 10.5312/wjo.v4.i3.100.
3
Endothelialized microfluidics for studying microvascular interactions in hematologic diseases.用于研究血液系统疾病中微血管相互作用的内皮化微流控技术
J Vis Exp. 2012 Jun 22(64):3958. doi: 10.3791/3958.
4
Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis.儿童感染产志贺样毒素大肠杆菌 O157:H7 后溶血尿毒综合征的危险因素:多变量分析。
Clin Infect Dis. 2012 Jul;55(1):33-41. doi: 10.1093/cid/cis299. Epub 2012 Mar 19.
5
In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology.使用微流控技术体外模拟血液疾病中发生的微血管闭塞和血栓形成。
J Clin Invest. 2012 Jan;122(1):408-18. doi: 10.1172/JCI58753. Epub 2011 Dec 12.
6
Clinical aspects of a nationwide epidemic of severe haemolytic uremic syndrome (HUS) in children.儿童全国范围内严重溶血尿毒综合征(HUS)流行的临床方面。
Scand J Trauma Resusc Emerg Med. 2011 Jul 28;19:44. doi: 10.1186/1757-7241-19-44.